Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NEJM Catalyst is a digital platform and peer-reviewed journal from the NEJM Group that focuses on the practical innovations and ideas needed to transform health care delivery. It provides healthcare executives, clinical leaders, and clinicians with a combination of peer-reviewed articles, case studies, and expert insights. The platform covers critical topics such as value-based care, patient engagement, and organizational change. By connecting a global community of healthcare professionals, NEJM Catalyst facilitates the sharing of best practices to improve patient outcomes and operational efficiency. It serves as a vital resource for those looking to implement scalable solutions in complex health systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NEJM Catalyst.